JWBC
BSX icon

John W. Brooker & Co’s Boston Scientific BSX Stock Holding History

John W. Brooker & Co’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-200
Closed -$8K – 76
2022
Q3 		$8K Hold
200
– – 0.01% 147
2022
Q2 		$7K Hold
200
– – ﹤0.01% 149
2022
Q1 		$9K Hold
200
– – ﹤0.01% 148
2021
Q4 		$8K Hold
200
– – ﹤0.01% 149
2021
Q3 		$9K Hold
200
– – 0.01% 145
2021
Q2 		$9K Hold
200
– – 0.01% 139
2021
Q1 		$8K Hold
200
– – 0.01% 133
2020
Q4 		$7K Hold
200
– – ﹤0.01% 132
2020
Q3 		$8K Hold
200
– – 0.01% 119
2020
Q2 		$7K Sell
200
-65
-25% -$2.34K 0.01% 124
2020
Q1 		$9K Hold
265
– – 0.01% 122
2019
Q4 		$12K Buy
+265
New +$11.1K 0.01% 121

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

John W. Brooker & Co's BSX Position: Q4 2022 in Review

John W. Brooker & Co sold out of Boston Scientific (BSX) in Q4 2022, closing a stake of 200 shares — an estimated $8K sold.

John W. Brooker & Co first reported a position in BSX in Q4 2019 and held it in 12 quarters. The position peaked at $12K in Q4 2019. 928 funds tracked by Wall St. Rank hold BSX as of Q4 2022.

  • John W. Brooker & Co reported no remaining Boston Scientific position as of Q4 2022 after selling out during the quarter.
  • John W. Brooker & Co sold 200 Boston Scientific shares in Q4 2022, an estimated $8K.
  • John W. Brooker & Co first reported a position in Boston Scientific in Q4 2019 and held it in 12 quarters.
  • John W. Brooker & Co's Boston Scientific position peaked at $12K in Q4 2019.
  • 928 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.

Based on John W. Brooker & Co's 13F filing for Q4 2022, filed 13 Jan 2023.